|
|
|
|
| Top Story |
 |
|
Who Will Head FDA? |
Time is running out on Ned Sharpless' term as FDA acting commissioner, generating much talk as the administration shows interest in naming a new head for the agency
… /Read more/ |
|
|
| Advertisement |
Launching Medical Devices in the Japanese Market
- How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
Register Now
|
|
| Industry Trends |
 |
|
Pharm Exec's Industry Audit 2019 |
Pharm Exec's latest analysis of financial performance reveals that it's those drugmakers maximizing the difference between the value and the cost of their capital investments that are delivering the most bang for the buck to shareholders
… /Read more/ |
|
|
|
|
|
|
|
| Industry update |
| //CymaBay Therapeutics (Newark, CA) announced that Pol Boudes, M.D., Chief Medical Officer, will be leaving the company on September 30, 2019 to explore other opportunities. CymaBay has initiated a formal search for his replacement.
//
Opiant Pharmaceuticals (Santa Monica, CA) announced the appointments of Aziz Mottiwala as Opiant's Chief Commercial Officer, and Rahsaan Thompson as General Counsel, two newly created positions.
//
Pressure BioSciences (South Easton, MA) appointed Daniel J. Shea Senior Vice President and Chief Financial Officer
//
Zomedica Pharmaceuticals Corp. (Ann Arbor, MI) promoted Dr. Stephanie Morley, Chief Operations Officer and VP of Product Development, to the role of President.
//
Soligenix (Princeton, NJ) appointed Daniel P. Ring as Vice President of Business Development and Strategic Planning, and Jonathan Guarino as Chief Financial Officer.
//
Imvax (Philadelphia, PA) announced that John P. Furey has been appointed as Chief Executive Officer (CEO).
//
Orchard Therapeutics' Chief Commercial Officer Jason Meyenburg has left the company to take on a chief executive role in the industry. Mark Rothera, Orchard's President and Chief Executive Officer, will assume global commercial leadership responsibilities. The company has initiated a global search for Mr. Meyenburg's permanent replacement.
//
|
|
|
|
|
|
|
|
|
